Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
American Journal of Veterinary Research
|
November 13, 2001
Correlations among time and frequency measures of heart rate variability recorded by use of a Holter monitor in overtly healthy Doberman pinschers with and without echocardiographic evidence of dilated cardiomyopathy
C A Calvert, T M Wall
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1994
Role of bradykinin in myocardial preconditioning
T M Wall, R Sheehy, J C Hartman
European Journal of Pharmacology
|
June 13, 1996
Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism
T M Wall, D A Linseman, J C Hartman
Journal of Molecular and Cellular Cardiology
|
September 1, 1994
The trolox analog, U-78517F, attenuates hypoxic injury in isolated cardiac myocytes
D A Linseman, T M Wall, J C Hartman
Journal of Oral Surgery (American Dental Association : 1965)
|
November 1, 1977
Clinicopathological conference. Case 20, part 2. Idiopathic gingival fibromatosis
J J Yurosko, T M Wall, J J Vopal, et al.
Journal of Oral Surgery (American Dental Association : 1965)
|
October 1, 1977
Clinicopathological conference. Case 20, part 1
J J Yurosko, T M Wall, J J Vopal, et al.
Journal of Cardiovascular Pharmacology
|
June 1, 1993
Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140
J C Hartman, T M Wall, T G Hullinger, et al.
European Journal of Pharmacology
|
April 6, 1993
Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition
J C Hartman, T G Hullinger, T M Wall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1994
Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat
J C Hartman, G M Kurc, T G Hullinger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 4, 2004
The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats
M Hajós, R S Hurst, W E Hoffmann, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
American Journal of Veterinary Research
|
November 13, 2001
Correlations among time and frequency measures of heart rate variability recorded by use of a Holter monitor in overtly healthy Doberman pinschers with and without echocardiographic evidence of dilated cardiomyopathy
C A Calvert, T M Wall
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1994
Role of bradykinin in myocardial preconditioning
T M Wall, R Sheehy, J C Hartman
European Journal of Pharmacology
|
June 13, 1996
Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism
T M Wall, D A Linseman, J C Hartman
Journal of Molecular and Cellular Cardiology
|
September 1, 1994
The trolox analog, U-78517F, attenuates hypoxic injury in isolated cardiac myocytes
D A Linseman, T M Wall, J C Hartman
Journal of Oral Surgery (American Dental Association : 1965)
|
November 1, 1977
Clinicopathological conference. Case 20, part 2. Idiopathic gingival fibromatosis
J J Yurosko, T M Wall, J J Vopal, et al.
Journal of Oral Surgery (American Dental Association : 1965)
|
October 1, 1977
Clinicopathological conference. Case 20, part 1
J J Yurosko, T M Wall, J J Vopal, et al.
Journal of Cardiovascular Pharmacology
|
June 1, 1993
Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140
J C Hartman, T M Wall, T G Hullinger, et al.
European Journal of Pharmacology
|
April 6, 1993
Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition
J C Hartman, T G Hullinger, T M Wall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1994
Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat
J C Hartman, G M Kurc, T G Hullinger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 4, 2004
The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats
M Hajós, R S Hurst, W E Hoffmann, et al.
Page
of 2